The State University of Maringá is a public university whose main campus is in Maringá, Paraná, Brazil. It was founded in 1970 and recognized in 1976 by the Federal Government of Brazil. Its academic population is estimated in 18,000 people among professors, undergraduates, graduate students and manager technicals.

During the past decade, Universidade Estabual de Maringa conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universidade Estabual de Maringa" #1 sponsor was "Mannkind Corporation" with 2 trials, followed by "Cardiol Therapeutics Inc." with 1 trials sponsored, "State University of Maringá" with 1 trials sponsored, "Universidade Estadual de Maringá" with 1 trials sponsored and "University of Alabama at Birmingham" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidade Estabual de Maringa" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universidade Estabual de Maringa" are "COVID-19" (1 trials), "Cardiovascular Diseases" (1 trials), "Cardiovascular Risk Factor" (1 trials), "Cervical Cancer" (1 trials) and "Cross-bite" (1 trials). Many other conditions were trialed in "Universidade Estabual de Maringa" in a lesser frequency.

Most popular intervention types in "Universidade Estabual de Maringa" are "Drug" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Active comparator" (1 trials), "Cannabidiol, pharmaceutically produced with < 5 ppm THC" (1 trials), "Choice" (1 trials) and "Pap testing" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidade Estabual de Maringa" are 4 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Universidade Estabual de Maringa". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Universidade Estabual de Maringa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universidade Estabual de Maringa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".